Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Similares em SciELO
Compartilhar
Cirugía y cirujanos
versão On-line ISSN 2444-054Xversão impressa ISSN 0009-7411
Resumo
YILDIRIM, Murat et al. Lymphocyte-to-C-reactive protein ratio as a new biomarker for predicting mortality and morbidity in Fourniers gangrene. Cir. cir. [online]. 2024, vol.92, n.2, pp.181-188. Epub 02-Ago-2024. ISSN 2444-054X. https://doi.org/10.24875/ciru.22000529.
Objective:
The purpose of this study was to research the neutrophil-lymphocyte ratio (NLR), lymphocyte-to-C-reactive protein ratio (LCR), and Fourniers Gangrene Severity Index (FGSI) for predicting prognosis and mortality in patients with Fournier´s gangrene (FG).
Material and Methods:
Patients diagnosed with FG and treated in a tertiary referral hospital in the period from January 2013 to June 2020 were reviewed. LCR, FGSI, and NLR values were calculated.
Results:
Our series included a total of 41 patients. Of the patients, 78% survived and 21.9% (n = 9) died. Survivors were significantly younger than non-survivors (p = 0.009). Hospital costs were higher in non-survivors and close to statistical significance (p = 0.08). The ROC analysis revealed that the FGSI, LCR, and NLR parameters were significant in identifying survivors and non-survivors (AUC = 0.941 [0.870-1.000], p < 0.001; AUC = 0.747 [0.593-0.900], p = 0.025; and AUC = 0.724 [0.548-0.900], p = 0.042).
Conclusion:
A low LCR value can be used as a marker to assess mortality and disease severity in patients with Fourniers gangrene.
Palavras-chave : Fourniers gangrene; Lymphocyte C-reactive protein ratio; Mortality; Cost effective.